Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods

Molecular and Cellular Proteomics

Volumn 10, Issue 9, 2011, Pages

  Thingholm, Tine E ^a,b   Bak, Steffen ^a,b   Beck Nielsen, Henning ^a   Jensen, Ole N ^b   Gaster, Michael ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; GLYCOGEN; INSULIN; METFORMIN; PROLYL DIPEPTIDASE; SULFONYLUREA; TRICHLOROACETIC ACID; DIPEPTIDYL PEPTIDASE IV; DPP4 PROTEIN, HUMAN; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; COMPLEMENTARY QUANTITATIVE MASS SPECTROMETRY; CONTROLLED STUDY; GLYCOGEN METABOLISM; GLYCOLYSIS; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIPID OXIDATION; MASS SPECTROMETRY; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CELL CULTURE; DOWN REGULATION; ENERGY METABOLISM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; INSULIN RESISTANCE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SKELETAL MUSCLE;

ADENOSINE DEAMINASE; BODY MASS INDEX; CASE-CONTROL STUDIES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL PEPTIDASE 4; DOWN-REGULATION; ENERGY METABOLISM; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; OBESITY; PROTEIN BINDING; PROTEOMICS; THINNESS;

EID: 80052772366     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.006650     Document Type: Article

References (65)

1. Amos, A. F., McCarty, D. J., and Zimmet, P. (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet. Med. 14 Suppl 5, S1-85
2. King, H., Aubert, R. E., and Herman, W. H. (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-1431 (Pubitemid 28405191)
3. Drewnowski, A. (2009) Obesity, diets, and social inequalities. Nutr. Rev. 67 Suppl 1, S36-9
4. Zimmet, P., Alberti, K. G., and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature 414, 782-787 (Pubitemid 34000780)
5. Inzucchi, S., and Sherman, R. (2005) The prevention of type 2 diabetes mellitus. Endocrinol. Meab. Clin. North Am. 34, 199-219 (Pubitemid 40332509)
6. American Diabetes Association, Total Prevalence of Diabetes and Pre-diabetes. http://www.diabetes.org/diabetes-statistics/prevalence-.jsp 2008
7. Zimmet, P. (2000) Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted? J. Intern. Med. 247, 301-310
8. Beck-Nielsen, H. (1998) Mechanisms of insulin resistance in non-oxidative glucose metabolism: the role of glycogen synthase. J. Basic Clin. Physiol. Pharmacol. 9, 255-279
9. Beck-Nielsen, H., and Groop, L. C. (1994) Metabolic and genetic characterization of prediabetic states. Sequence of events leading to noninsulin-dependent diabetes mellitus. J. Clin. Invest. 94, 1714-1721
10. Beck-Nielsen, H., Vaag, A., Poulsen, P., and Gaster, M. (2003) Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects-experiences from relatives and twin studies. Best Pract. Res. Clin. Endocrinol. Metab. 17, 445-467
11. Højlund, K., Gaster, M., and Beck-Nielsen, H. (2007) Tissue Biopsies in Diabetes Research. Clinical Diabetes Research: Methods and Techniques, ISBN 9780470017289, John Wiley and Son
12. Yi, Z., Bowen, B. P., Hwang, H., Jenkinson, C. P., Coletta, D. K., Lefort, N., Bajaj, M., Kashyap, S., Berria, R., De Filippis, E. A., and Mandarino, L. J. (2008) Global relationship between the proteome and transcriptome of human skeletal muscle. J. Proteome Res. 7, 3230-3241
13. Højlund, K., Yi, Z., Hwang, H., Bowen, B., Lefort, N., Flynn, C. R., Langlais, P., Weintraub, S. T., and Mandarino, L. J. (2008) Characterization of the human skeletal muscle proteome by one-dimensional gel electrophoresis and HPLC-ESI-MS/MS. Mol. Cell Proteomics 7, 257-267 (Pubitemid 351298440)
14. Anderson, L., and Seilhamer, J. (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18, 533-537 (Pubitemid 27174443)
15. Gygi, S. P., Rochon, Y., Franza, B. R., and Aebersold, R. (1999) Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19, 1720-1730 (Pubitemid 29098230)
16. Henry, R. R., Abrams, L., Nikoulina, S., and Ciaraldi, T. P. (1995) Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 44, 936-946
17. Henry, R. R., Ciaraldi, T. P., Mudaliar, S., Abrams, L., and Nikoulina, S. E. (1996) Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels. Diabetes 45, 400-407 (Pubitemid 26110243)
18. Gaster, M., and Beck-Nielsen, H. (2004) The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin-evidence from cultured myotubes. Biochim. Biophys. Acta 1690, 85-91
19. Gaster, M., Brüsgaard, K., Handberg, A., Højlund, K., Wojtaszewski, J. F., and Beck-Nielsen, H. (2004) The primary defect in glycogen synthase activity is not based on increased glycogen synthase kinase-3alpha activity in diabetic myotubes. Biochem. Biophys. Res. Commun. 319, 1235-1240 (Pubitemid 38759543)
20. Gaster, M., Rustan, A. C., Aas, V., and Beck-Nielsen, H. (2004) Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 53, 542-548
21. Gaster, M., Petersen, I., Højlund, K., Poulsen, P., and Beck-Nielsen, H. (2002) The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 51, 921-927 (Pubitemid 34438332)
22. Gaster, M., Kristensen, S. R., Beck-Nielsen, H., and Schrøder, H. D. (2001) A cellular model system of differentiated human myotubes. APMIS 109, 735-744 (Pubitemid 34015455)
23. Gaster, M. (2007) Reduced TCA -flux in diabetic myotubes: A governing influence on the diabetic phenotype ? Biochem. Biophys. Res. Commun. 1772, 755-765
24. Gaster, M. (2009) Reduced lipid oxidation in human myotubes established from obese and type 2 diabetic subjects. Biochem. Biophys. Res. Commun. 382, 766-770
25. Minet, A. D., and Gaster, M. (2010) ATP synthesis is impaired in isolated mitochondria from myotubes established from type 2 diabetic subjects. Biochem. Biophys. Res. Commun. 402, 70-74
26. Oda, Y., Huang, K., Cross, F. R., Cowburn, D., and Chait, B. T. (1999) Accurate quantitation of protein expression and site-specific phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 96, 6591-6596 (Pubitemid 29274927)
27. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 1, 376-386
28. Zhu, H., Pan, S., Gu, S., Bradbury, E. M., and Chen, X. (2002) Amino acid residue specific stable isotope labeling for quantitative proteomics. Rapid Commun. Mass Spectrom. 16, 2115-2123 (Pubitemid 35340078)
29. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 3, 1154-1169
30. Lange, V., Picotti, P., Domon, B., and Aebersold, R. (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 4, 222
31. Picotti, P., Bodenmiller, B., Mueller, L. N., Domon, B., and Aebersold, R. (2009) Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138, 795-806
32. Ortenblad, N., Mogensen, M., Petersen, I., Højlund, K., Levin, K., Sahlin, K., Beck-Nielsen, H., and Gaster, M. (2005) Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Biochim. Biophys. Acta 1741, 206-214 (Pubitemid 40825006)
33. Gaster, M., and Beck-Nielsen, H. (2006) Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects. Biochim. Biophys. Acta 1761, 100-110
34. Bergstrom, J. (1975) Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand. J. Clin. Lab. Invest. 35, 609-616
35. Gaster, M., Beck-Nielsen, H., and Schrøder, H. D. (2001) Proliferation conditions for human satellite cells. The fractional content of satellite cells. APMIS 109, 726-734 (Pubitemid 34015454)
36. Gaster, M., Schrøder, H. D., Handberg, A., and Beck-Nielsen, H. (2001) The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure. Biochim. Biophys. Acta 1537, 211-221 (Pubitemid 33139803)
37. Gaster, M. (2009) The dynamic of lipid oxidation in human myotubes. Biochim. Biophys. Acta 1791, 17-24
38. Gobom, J., Nordhoff, E., Mirgorodskaya, E., Ekman, R., and Roepstorff, P. (1999) Sample purification and preparation technique based on nanoscale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 34, 105-116
39. Thingholm, T. E., Jensen, O. N., Robinson, P. J., and Larsen, M. R. (2008) SIMAC - A phosphoproteomic strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol Cell Proteomics 7, 661-671 (Pubitemid 351597478)
40. Rewitz, K. F., Larsen, M. R., Lobner-Olesen, A., Rybczynski, R., O'Connor, M. B., and Gilbert, L. I. (2009) A phosphoproteomics approach to elucidate neuropeptide signal transduction controlling insect metamorphosis. Insect Biochem. Mol. Biol. 39, 475-483
41. Mallick, P., Schirle, M., Chen, S. S., Flory, M. R., Lee, H., Martin, D., Ranish, J., Raught, B., Schmitt, R., Werner, T., Kuster, B., and Aebersold, R. (2007) Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol. 25, 125-131 (Pubitemid 46098780)
42. Thompson, A., Schäfer, J., Kuhn, K., Kienle, S., Schwarz, J., Schmidt, G., Neumann, T., Johnstone, R., Mohammed, A. K., and Hamon, C. (2003) Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem. 75, 1895-1904 (Pubitemid 36438013)
43. Thingholm, T. E., Palmisano, G., Kjeldsen, F., and Larsen, M. R. (2010) Undesirable Charge-Enhancement of Isobaric Tagged Phosphopeptides Leads to Reduced Identification Efficiency. J. Proteome Res 9, 4045-4052
44. Kjeldsen, F., Giessing, A. M., Ingrell, C. R., and Jensen, O. N. (2007) Peptide sequencing and characterization of post-translational modifications by enhanced ion-charging and liquid chromatography electron-transfer dissociation tandem mass spectrometry. Anal. Chem. 79, 9243-9252 (Pubitemid 350276301)
45. Olsen, J. V., Schwartz, J. C., Griep-Raming, J., Nielsen, M. L., Damoc, E., Denisov, E., Lange, O., Remes, P., Taylor, D., Splendore, M., Wouters, E. R., Senko, M., Makarov, A., Mann, M., and Horning, S. (2009) A dual pressure linear ion trap Orbitrap instrument with very high sequencing speed. Mol. Cell Proteomics 8, 2759-2769
46. Sreekumar, R., Halvatsiotis, P., Schimke, J. C., and Nair, K. S. (2002) Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51, 1913-1920 (Pubitemid 34564306)
47. Frederiksen, C. M., Højlund, K., Hansen, L., Oakeley, E. J., Hemmings, B., Abdallah, B. M., Brusgaard, K., Beck-Nielsen, H., and Gaster, M. (2008) Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia 51, 2068-2077
48. Gaster, M., Staehr, P., Beck-Nielsen, H., Schrøder, H. D., and Handberg, A. (2001) GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes 50, 1324-1329 (Pubitemid 32500164)
49. Nyholm, B., Qu, Z., Kaal, A., Pedersen, S. B., Gravholt, C. H., Andersen, J. L., Saltin, B., and Schmitz, O. (1997) Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes 46, 1822-1828 (Pubitemid 27456417)
50. Bell, G. I., Xiang, K. S., Newman, M. V., Wu, S. H., Wright, L. G., Fajans, S. S., Spielman, R. S., and Cox, N. J. (1991) Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc. Natl. Acad. Sci. U.S.A. 88, 1484-1488 (Pubitemid 21916249)
51. Fajans, S. S. (1989) Maturity-onset diabetes of the young (MODY). Diabetes Metab. Rev. 5, 579-606
52. Fajans, S. S. (1990) Scope and heterogeneous nature of MODY. Diabetes Care 13, 49-64
53. Leighton, B., Lozeman, F. J., Vlachonikolis, I. G., Challiss, R. A., Pitcher, J. A., and Newsholme, E. A. (1988) Effects of adenosine deaminase on the sensitivity of glucose transport, glycolysis and glycogen synthesis to insulin in muscles of the rat. Int. J. Biochem. 20, 23-27
54. Green, B. D., Flatt, P. R., and Bailey, C. J. (2006) Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes. Diab. Vasc. Dis. Res. 3, 159-165 (Pubitemid 44902481)
55. Gorrell, M. D., Gysbers, V., and McCaughan, G. W. (2001) CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J. Immunol. 54, 249-264 (Pubitemid 34205737)
56. Drucker, D. J. (2003) Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes. Expert Opin. Investig. Drugs 12, 87-100
57. Ahn, J. H., Shin, M. S., Jun, M. A., Jung, S. H., Kang, S. K., Kim, K. R., Rhee, S. D., Kang, N. S., Kim, S. Y., Sohn, S. K., Kim, S. G., Jin, M. S., Lee, J. O., Cheon, H. G., and Kim, S. S. (2007) Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors. Bioorg. Med. Chem. Lett. 17, 2622-2628 (Pubitemid 46509838)
58. Augustyns, K., Bal, G., Thonus, G., Belyaev, A., Zhang, X. M., Bollaert, W., Lambeir, A. M., Durinx, C., Goossens, F., and Haemers, A. (1999) The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors. Curr. Med. Chem. 6, 311-327 (Pubitemid 29226115)
59. Augustyns, K., Van der Veken, P., Senten, K., and Haemers, A. (2005) The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases. Curr. Med. Chem. 12, 971-998 (Pubitemid 40443851)
60. Ferraris, D., Belyakov, S., Li, W., Oliver, E., Ko, Y. S., Calvin, D., Lautar, S., Thomas, B., and Rojas, C. (2007) Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV). Curr. Top Med. Chem. 7, 597-608 (Pubitemid 46488282)
61. Ferraris, D., Ko, Y. S., Calvin, D., Chiou, T., Lautar, S., Thomas, B., Wozniak, K., Rojas, C., Kalish, V., and Belyakov, S. (2004) Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors. Bioorg. Med. Chem. Lett. 14, 5579-5583 (Pubitemid 39346349)
62. Kowalchick, J. E., Leiting, B., Pryor, K. D., Marsilio, F., Wu, J. K., He, H., Lyons, K. A., Eiermann, G. J., Petrov, A., Scapin, G., Patel, R. A., Thornberry, N. A., Weber, A. E., and Kim, D. (2007) Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors. Bioorg. Med. Chem. Lett. 17, 5934-5939 (Pubitemid 47446206)
63. Green, B. D., Irwin, N., Duffy, N. A., Gault, V. A., O'harte, F, P., and Flatt, P. R. (2006) Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1. Eur. J. Pharmacol. 547, 192-199 (Pubitemid 44373906)
64. Liu, X., Feng, Q., Chen, Y., Zuo, J., Gupta, N., Chang, Y., and Fang, F. (2009) Proteomics-based identification of differentially-expressed proteins including galectin-1 in the blood plasma of type 2 diabetic patients. J. Proteome Res. 8, 1255-1262
65. Mooradian, A. D., Haas, M. J., and Wong, N. C. (2004) Transcriptional control of apolipoprotein A-I gene expression in diabetes. Diabetes 53, 513-520 (Pubitemid 38270617)